ShareHope Medicine Statistics
Total Valuation
ShareHope Medicine has a market cap or net worth of TWD 3.77 billion. The enterprise value is 4.77 billion.
Market Cap | 3.77B |
Enterprise Value | 4.77B |
Important Dates
The last earnings date was Monday, November 11, 2024.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ShareHope Medicine has 131.09 million shares outstanding. The number of shares has increased by 0.74% in one year.
Current Share Class | n/a |
Shares Outstanding | 131.09M |
Shares Change (YoY) | +0.74% |
Shares Change (QoQ) | -1.91% |
Owned by Insiders (%) | 0.05% |
Owned by Institutions (%) | 0.65% |
Float | 131.03M |
Valuation Ratios
The trailing PE ratio is 24.14.
PE Ratio | 24.14 |
Forward PE | n/a |
PS Ratio | 0.88 |
PB Ratio | 1.05 |
P/TBV Ratio | n/a |
P/FCF Ratio | 20.21 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.68, with an EV/FCF ratio of 25.58.
EV / Earnings | 30.36 |
EV / Sales | 1.11 |
EV / EBITDA | 11.68 |
EV / EBIT | 44.04 |
EV / FCF | 25.58 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.50.
Current Ratio | 1.78 |
Quick Ratio | 1.55 |
Debt / Equity | 0.50 |
Debt / EBITDA | 4.90 |
Debt / FCF | 10.73 |
Interest Coverage | 1.95 |
Financial Efficiency
Return on equity (ROE) is 2.45% and return on invested capital (ROIC) is 1.12%.
Return on Equity (ROE) | 2.45% |
Return on Assets (ROA) | 0.93% |
Return on Capital (ROIC) | 1.12% |
Revenue Per Employee | 36.28M |
Profits Per Employee | 1.33M |
Employee Count | 118 |
Asset Turnover | 0.59 |
Inventory Turnover | 11.53 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.58% in the last 52 weeks. The beta is 0.51, so ShareHope Medicine's price volatility has been lower than the market average.
Beta (5Y) | 0.51 |
52-Week Price Change | -9.58% |
50-Day Moving Average | 29.86 |
200-Day Moving Average | 30.49 |
Relative Strength Index (RSI) | 33.33 |
Average Volume (20 Days) | 152,064 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ShareHope Medicine had revenue of TWD 4.28 billion and earned 157.13 million in profits. Earnings per share was 1.19.
Revenue | 4.28B |
Gross Profit | 766.94M |
Operating Income | 107.92M |
Pretax Income | 149.35M |
Net Income | 157.13M |
EBITDA | 281.42M |
EBIT | 107.92M |
Earnings Per Share (EPS) | 1.19 |
Balance Sheet
The company has 1.46 billion in cash and 2.00 billion in debt, giving a net cash position of -541.91 million or -4.13 per share.
Cash & Cash Equivalents | 1.46B |
Total Debt | 2.00B |
Net Cash | -541.91M |
Net Cash Per Share | -4.13 |
Equity (Book Value) | 3.98B |
Book Value Per Share | 27.30 |
Working Capital | 1.39B |
Cash Flow
In the last 12 months, operating cash flow was 310.30 million and capital expenditures -123.81 million, giving a free cash flow of 186.48 million.
Operating Cash Flow | 310.30M |
Capital Expenditures | -123.81M |
Free Cash Flow | 186.48M |
FCF Per Share | 1.42 |
Margins
Gross margin is 17.92%, with operating and profit margins of 2.52% and 3.67%.
Gross Margin | 17.92% |
Operating Margin | 2.52% |
Pretax Margin | 3.49% |
Profit Margin | 3.67% |
EBITDA Margin | 6.57% |
EBIT Margin | 2.52% |
FCF Margin | 4.36% |
Dividends & Yields
This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 1.34%.
Dividend Per Share | 0.38 |
Dividend Yield | 1.34% |
Dividend Growth (YoY) | -16.80% |
Years of Dividend Growth | 5 |
Payout Ratio | 32.74% |
Buyback Yield | -0.74% |
Shareholder Yield | 0.60% |
Earnings Yield | 4.14% |
FCF Yield | 4.95% |
Stock Splits
The last stock split was on August 27, 2024. It was a forward split with a ratio of 1.040000001.
Last Split Date | Aug 27, 2024 |
Split Type | Forward |
Split Ratio | 1.040000001 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |